» Articles » PMID: 35982967

Research Trends of Artificial Intelligence in Pancreatic Cancer: a Bibliometric Analysis

Overview
Journal Front Oncol
Specialty Oncology
Date 2022 Aug 19
PMID 35982967
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We evaluated the related research on artificial intelligence (AI) in pancreatic cancer (PC) through bibliometrics analysis and explored the research hotspots and current status from 1997 to 2021.

Methods: Publications related to AI in PC were retrieved from the Web of Science Core Collection (WoSCC) during 1997-2021. Bibliometrix package of R software 4.0.3 and VOSviewer were used to bibliometrics analysis.

Results: A total of 587 publications in this field were retrieved from WoSCC database. After 2018, the number of publications grew rapidly. The United States and Johns Hopkins University were the most influential country and institution, respectively. A total of 2805 keywords were investigated, 81 of which appeared more than 10 times. Co-occurrence analysis categorized these keywords into five types of clusters: (1) AI in biology of PC, (2) AI in pathology and radiology of PC, (3) AI in the therapy of PC, (4) AI in risk assessment of PC and (5) AI in endoscopic ultrasonography (EUS) of PC. Trend topics and thematic maps show that keywords " diagnosis ", "survival", "classification", and "management" are the research hotspots in this field.

Conclusion: The research related to AI in pancreatic cancer is still in the initial stage. Currently, AI is widely studied in biology, diagnosis, treatment, risk assessment, and EUS of pancreatic cancer. This bibliometrics study provided an insight into AI in PC research and helped researchers identify new research orientations.

Citing Articles

Artificial Intelligence in Pancreatic Imaging: A Systematic Review.

Podina N, Gheorghe E, Constantin A, Cazacu I, Croitoru V, Gheorghe C United European Gastroenterol J. 2025; 13(1):55-77.

PMID: 39865461 PMC: 11866320. DOI: 10.1002/ueg2.12723.


A bibliometric analysis of vaccination against atherosclerosis.

Jia B, Wei R, Yuan C, Cheng T, Shi S, Chu Y Hum Vaccin Immunother. 2024; 20(1):2365500.

PMID: 39693182 PMC: 11188792. DOI: 10.1080/21645515.2024.2365500.


Data privacy-aware machine learning approach in pancreatic cancer diagnosis.

Akmese O BMC Med Inform Decis Mak. 2024; 24(1):248.

PMID: 39237927 PMC: 11375871. DOI: 10.1186/s12911-024-02657-2.


Systematic review of predictive maintenance and digital twin technologies challenges, opportunities, and best practices.

Abd Wahab N, Hasikin K, Lai K, Xia K, Bei L, Huang K PeerJ Comput Sci. 2024; 10:e1943.

PMID: 38686003 PMC: 11057655. DOI: 10.7717/peerj-cs.1943.


From Machine Learning to Patient Outcomes: A Comprehensive Review of AI in Pancreatic Cancer.

Tripathi S, Tabari A, Mansur A, Dabbara H, Bridge C, Daye D Diagnostics (Basel). 2024; 14(2).

PMID: 38248051 PMC: 10814554. DOI: 10.3390/diagnostics14020174.


References
1.
Zhang Z, Wang J, Zulfiqar H, Lv H, Dao F, Lin H . Early Diagnosis of Pancreatic Ductal Adenocarcinoma by Combining Relative Expression Orderings With Machine-Learning Method. Front Cell Dev Biol. 2020; 8:582864. PMC: 7593596. DOI: 10.3389/fcell.2020.582864. View

2.
Barat M, Chassagnon G, Dohan A, Gaujoux S, Coriat R, Hoeffel C . Artificial intelligence: a critical review of current applications in pancreatic imaging. Jpn J Radiol. 2021; 39(6):514-523. DOI: 10.1007/s11604-021-01098-5. View

3.
Tonozuka R, Itoi T, Nagata N, Kojima H, Sofuni A, Tsuchiya T . Deep learning analysis for the detection of pancreatic cancer on endosonographic images: a pilot study. J Hepatobiliary Pancreat Sci. 2020; 28(1):95-104. DOI: 10.1002/jhbp.825. View

4.
Han I, Cho K, Ryu Y, Shin S, Heo J, Choi D . Risk prediction platform for pancreatic fistula after pancreatoduodenectomy using artificial intelligence. World J Gastroenterol. 2020; 26(30):4453-4464. PMC: 7438201. DOI: 10.3748/wjg.v26.i30.4453. View

5.
Boursi B, Finkelman B, Giantonio B, Haynes K, Rustgi A, Rhim A . A clinical prediction model to assess risk for pancreatic cancer among patients with prediabetes. Eur J Gastroenterol Hepatol. 2021; 34(1):33-38. PMC: 8286263. DOI: 10.1097/MEG.0000000000002052. View